semaglutide aha Late Breaking Science: Day 1 Highlights π«SELECT Trial: and Cardiovascular Outcomes in Obesity without Diabetes β: β¬οΈ 20% Risk of a composite of cardiovascular death β€οΈ, nonfatal myocardial infarction, or GLP-1 Drugs Lower Risk of
Description
12 Besides setmelanotide, which is indicated for patients with rare genetic forms of obesity, these alternative anti-obesity medications result in modest weight loss, typically ranging from 3 to 9% of baseline body weight
Can retatrutide cause chills or temperature changes as side effects?
PC: Formal analysis, Investigation, Methodology, Writing original draft
The main difference is the amount of medication used
When considering options beyond Ozempic for weight management, it's important to understand how these alternatives differ
Gastrointestinal symptoms like constipation or diarrhea may persist longersometimes 23 monthsbut become much milder over time
